Drug class in one race
Multi-target (ginsenoside) drugs for Alzheimer's Disease
3 tracked Multi-target (ginsenoside) drugs in the Alzheimer's Disease race. The class explanation lives on the Multi-target (ginsenoside) page; the full indication pipeline across every mechanism is on the Alzheimer's Disease page.
1 Phase 31 Phase 2/31 Phase 2
Head-to-head evidence: Cerebrolysin vs MLC901 · Cerebrolysin vs PM012 · MLC901 vs PM012